Takeshi Hanagiri

Epithelial-mesenchymal transition in EGFR-TKI acquired resistant lung adenocarcinoma.

Hidetaka Uramoto, Teruo Iwata, Takamitsu Onitsuka et al. · PubMed · 2010 · 170 citations

Medicine, Molecular Biology, Oncology +17

Acquired resistance to gefitinib: The contribution of mechanisms other than the T790M, MET, and HGF status

Takamitsu Onitsuka, Hidetaka Uramoto, Naohiro Nose et al. · Lung Cancer · 2009 · 151 citations

Medicine, Pharmacology, Pharmacotherapy +10

Correlation between tumor regression and T cell responses in melanoma patients vaccinated with a MAGE antigen

Christophe Lonchay, Pierre van der Bruggen, Thierry Connerotte et al. · Proceedings of the National Academy of Sciences · 2004 · 148 citations · Full text

Life Sciences, Immunology, Oncology +17

Mutations within the tyrosine kinase domain of EGFR gene specifically occur in lung adenocarcinoma patients with a low exposure of tobacco smoking

Kenji Sugio, Hidetaka Uramoto, Kenji Ono et al. · British Journal of Cancer · 2006 · 139 citations · Full text

Medicine, Oncology, Pharmacology +15

Clinical significance of cancer/testis antigens expression in patients with non-small cell lung cancer

Yoshiki Shigematsu, Takeshi Hanagiri, Hironobu Shiota et al. · Lung Cancer · 2009 · 117 citations

Medicine, Cancer Biology, Oncology +16